Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467597 · ClinicalTrials.gov registry record
Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
A clinical trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- 36
- Enrollment target
NCT00467597 is a clinical trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 36 participants.
The verdict
NCT00467597 has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- 36 participants
- Enrollment target
Study Summary
The ultimate goal of this proposal is to reduce dyskinesia in Parkinson's Disease (PD) patients. Dyskinesias are abnormal movements, often caused by the standard treatment for PD symptoms, levodopa. In this study, we will test if biochemical devices are equal to the clinical rating system in measuring dyskinesias.
Interventions
- DRUG Levodopa (delivered intravenously)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2006-04 |
| Est. Completion | 2013-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00467597
The ClinicalTrials.gov registry entry for NCT00467597 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Levodopa (delivered intravenously) is the first listed.
NCT00467597 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00467597 about?
NCT00467597 is a clinical study titled "Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)". The ultimate goal of this proposal is to reduce dyskinesia in Parkinson's Disease (PD) patients. Dyskinesias are abnormal movements, often caused by the standard treatment for PD symptoms, levodopa. In this study, we will test if biochemical devices are equal to the clinical rating system in measuri...
What is the current status of trial NCT00467597?
This trial is currently completed. The enrollment target is 36 participants. The study started on 2006-04. Estimated completion is 2013-10.
What interventions are being tested in trial NCT00467597?
The interventions under investigation include: Levodopa (delivered intravenously) (DRUG).
Who is sponsoring clinical trial NCT00467597?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.